Serveur d'exploration MERS - Curation (Ncbi)

Index « Keywords » - entrée « Severe Acute Respiratory Syndrome (immunology) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Severe Acute Respiratory Syndrome (history) < Severe Acute Respiratory Syndrome (immunology) < Severe Acute Respiratory Syndrome (metabolism)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000543 (2007) Jun Huang [République populaire de Chine] ; Yingnan Cao [République populaire de Chine] ; Jiali Du [République populaire de Chine] ; Xianzhang Bu [République populaire de Chine] ; Rui Ma [République populaire de Chine] ; Changyou Wu [République populaire de Chine]Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses
000B47 (2013) Daniela Niemeyer [Allemagne] ; Thomas Zillinger ; Doreen Muth ; Florian Zielecki ; Gabor Horvath ; Tasnim Suliman ; Winfried Barchet ; Friedemann Weber ; Christian Drosten ; Marcel A. MüllerMiddle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist.
000B68 (2013) Susanna K P. Lau [République populaire de Chine] ; Candy C Y. Lau [République populaire de Chine] ; Kwok-Hung Chan [République populaire de Chine] ; Clara P Y. Li [République populaire de Chine] ; Honglin Chen [République populaire de Chine] ; Dong-Yan Jin [République populaire de Chine] ; Jasper F W. Chan [République populaire de Chine] ; Patrick C Y. Woo [République populaire de Chine] ; Kwok-Yung Yuen [République populaire de Chine]Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.
000D03 (2014) Jaffar A. Al-Tawfiq [Arabie saoudite] ; Ziad A. MemishWhat are our pharmacotherapeutic options for MERS-CoV?
000D08 (2014) Jincun Zhao [États-Unis] ; Kun Li ; Christine Wohlford-Lenane ; Sudhakar S. Agnihothram ; Craig Fett ; Jingxian Zhao ; Michael J. Gale ; Ralph S. Baric ; Luis Enjuanes ; Tom Gallagher ; Paul B. Mccray ; Stanley PerlmanRapid generation of a mouse model for Middle East respiratory syndrome.
000D72 (2014) Rudragouda Channappanavar ; Jincun Zhao ; Stanley PerlmanT cell-mediated immune response to respiratory coronaviruses
000E35 (2015) John Mair-Jenkins ; Maria Saavedra-Campos ; J Kenneth Baillie [Royaume-Uni] ; Paul Cleary ; Fu-Meng Khaw ; Wei Shen Lim ; Sophia Makki ; Kevin D. Rooney [Royaume-Uni] ; Jonathan S. Nguyen-Van-Tam ; Charles R. Beck [Royaume-Uni]The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.
000E37 (2014) Jaffar A. Al-Tawfiq [États-Unis] ; Alimuddin Zumla ; Ziad A. MemishCoronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers.
000F41 (2014) Mohammad Ali Moni [Bangladesh] ; Pietro LiNetwork-based analysis of comorbidities risk during an infection: SARS and HIV case studies
000F98 (2015) Yoshikazu Honda-Okubo [Australie] ; Dale Barnard [États-Unis] ; Chun Hao Ong [Australie] ; Bi-Hung Peng [États-Unis] ; Chien-Te Kent Tseng [États-Unis] ; Nikolai Petrovsky [Australie]Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.
001472 (2016) Rahul Vijay [États-Unis] ; Stanley Perlman [États-Unis]Middle East respiratory syndrome and severe acute respiratory syndrome
001523 (2016) Oi-Wing Ng [Singapour] ; Adeline Chia [Singapour] ; Anthony T. Tan [Singapour] ; Ramesh S. Jadi [Singapour] ; Hoe Nam Leong [Singapour] ; Antonio Bertoletti [Singapour] ; Yee-Joo Tan [Singapour]Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
001572 (2015) Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant
001657 (2016) Jincun Zhao [République populaire de Chine, États-Unis] ; Jingxian Zhao [États-Unis] ; Ashutosh K. Mangalam [États-Unis] ; Rudragouda Channappanavar [États-Unis] ; Craig Fett [États-Unis] ; David K. Meyerholz [États-Unis] ; Sudhakar Agnihothram [États-Unis] ; Ralph S. Baric [États-Unis] ; Chella S. David [États-Unis] ; Stanley Perlman [États-Unis]Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses
001673 (2016) Emmie De Wit ; Neeltje Van Doremalen ; Darryl Falzarano ; Vincent J. MunsterSARS and MERS: recent insights into emerging coronaviruses
001800 (2016) E. Kindler [Suisse] ; V. Thiel [Suisse] ; F. Weber [Allemagne]Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response
001844 (2016) William J. Liu [République populaire de Chine] ; Min Zhao [République populaire de Chine] ; Kefang Liu [République populaire de Chine] ; Kun Xu [République populaire de Chine] ; Gary Wong [République populaire de Chine] ; Wenjie Tan [République populaire de Chine] ; George F. Gao [République populaire de Chine]T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
002068 (2019) Naoko Iwata-Yoshikawa [Japon] ; Tadashi Okamura [Japon] ; Yukiko Shimizu [Japon] ; Hideki Hasegawa [Japon] ; Makoto Takeda [Japon] ; Noriyo Nagata [Japon]TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection.
002357 (2019) Fatima Abdirizak ; Rayleen Lewis ; Gerardo ChowellEvaluating the potential impact of targeted vaccination strategies against severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks in the healthcare setting
002627 (2020) Ling Lin [République populaire de Chine] ; Lianfeng Lu [République populaire de Chine] ; Wei Cao [République populaire de Chine] ; Taisheng Li [République populaire de Chine]Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.
002634 (????) Piercarlo Sarzi-Puttini [Italie] ; Valeria Giorgi [Italie] ; Silvia Sirotti [Italie] ; Daniela Marotto [Italie] ; Sandro Ardizzone [Italie] ; Giuliano Rizzardini [Italie] ; Spinello Antinori [Italie] ; Massimo Galli [Italie]COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Severe Acute Respiratory Syndrome (immunology)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Severe Acute Respiratory Syndrome (immunology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Severe Acute Respiratory Syndrome (immunology)
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021